Literature DB >> 6693167

Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens.

G A Tannock, J A Paul, R D Barry.   

Abstract

The immunogenicity of several cold-adapted (ca) viruses was compared in CSL mice with that of wild-type parental viruses with similar surface antigens, according to the vaccinating dose required to clear a challenge consisting of 10(4.5) 50% tissue culture infective doses of the wild-type virus. All ca viruses were less immunogenic than their wild-type parental strains by a factor of 10(1.3) to 10(3.4), probably due to the restricted capacity of ca viruses to replicate in the respiratory tracts of mice. However, their immunogenicity was considerably enhanced when two quite small doses were administered 3 weeks apart. The immunogenicity of ca viruses when administered in two doses and wild-type viruses when administered as a single dose varied according to their surface antigens. It was highest for viruses with the H2N2 A/Ann Arbor/6/60 and H3N2 A/Queensland/6/72 surface antigens and lowest for those with H1N1 A/HK/123/77 surface antigens. When two doses consisting of 10(5.0) 50% tissue culture infective doses of A/Ann Arbor/6/60-ca were administered at an interval of 3 weeks, solid immunity was induced against the wild-type A/Ann Arbor/6/60 parental virus, two heterologous H3N2 strains, and an H1N1 strain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6693167      PMCID: PMC264316          DOI: 10.1128/iai.43.2.457-462.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Naturally acquired immunity to influenza type A: a clinical and laboratory study.

Authors:  P W Gill; A M Murphy
Journal:  Med J Aust       Date:  1976-08-28       Impact factor: 7.738

2.  Biologic and immunologic characteristics of cold-adapted influenza virus.

Authors:  H F Maassab
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

3.  Studies with a cold-recombinant A/Victoria/3/75 (H3N2) virus. II. Evaluation in adult volunteers.

Authors:  A J Mortiz; C Kunz; H Hofman; E Liehl; P Reeve; H F Maassab
Journal:  J Infect Dis       Date:  1980-12       Impact factor: 5.226

4.  Comparative studies of wild-type and cold-mutant (temperature-sensitive) influenza viruses: nonrandom reassortment of genes during preparation of live virus vaccine candidates by recombination at 25 degrees between recent H3N2 and H1N1 epidemic strains and cold-adapted A/An Arbor/6/60.

Authors:  N J Cox; H F Maassab; A P Kendal
Journal:  Virology       Date:  1979-08       Impact factor: 3.616

5.  Cold adapted variants of influenza A. II. Comparison of the genetic and biological properties of ts mutants and recombinants of the cold adapted A/AA/6/60 strain.

Authors:  S B Spring; H F Maassab; A P Kendal; B R Murphy; R M Chanock
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

6.  Differing virulence of H1N1 and H3N2 influenza strains.

Authors:  P F Wright; J Thompson; D T Karzon
Journal:  Am J Epidemiol       Date:  1980-12       Impact factor: 4.897

7.  Influenza virus infection of a newborn rats: virulence of recombinant strains prepared from a cold-adapted, attenuated parent.

Authors:  M I Mahmud; H F Maassab; R Jennings; C W Potter
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

8.  Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.

Authors:  B R Murphy; H P Holley; E J Berquist; M M Levine; S B Spring; H F Maassab; A P Kendal; R M Chanock
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

9.  Cross-reactivity for different type A influenza viruses of a cloned T-killer cell line.

Authors:  L Y Lu; B A Askonas
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

10.  Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.

Authors:  R B Effros; P C Doherty; W Gerhard; J Bennink
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

View more
  44 in total

1.  A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge.

Authors:  G Deliyannis; J S Boyle; J L Brady; L E Brown; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  An M2 cytoplasmic tail mutant as a live attenuated influenza vaccine against pandemic (H1N1) 2009 influenza virus.

Authors:  Yasuko Hatta; Masato Hatta; Pamuk Bilsel; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Vaccine       Date:  2011-01-25       Impact factor: 3.641

3.  Mapping the pulmonary environment of animals protected from virulent H1N1 influenza infection using the TLR-2 agonist Pam₂Cys.

Authors:  Edin J Mifsud; Amabel C L Tan; Patrick C Reading; David C Jackson
Journal:  Immunol Cell Biol       Date:  2015-08-14       Impact factor: 5.126

4.  A virus-specific CD8+ T cell immunodominance hierarchy determined by antigen dose and precursor frequencies.

Authors:  Nicole L La Gruta; Katherine Kedzierska; Ken Pang; Richard Webby; Miles Davenport; Weisan Chen; Stephen J Turner; Peter C Doherty
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

5.  The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutinin gene.

Authors:  G A Tannock; J R Romanova; J A Paul
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Competition within the virus-specific CD4 T-cell pool limits the T follicular helper response after influenza infection.

Authors:  Matthew R Olson; Brendon Y Chua; Kim L Good-Jacobson; Peter C Doherty; David C Jackson; Stephen J Turner
Journal:  Immunol Cell Biol       Date:  2016-04-22       Impact factor: 5.126

7.  Salivary Blockade Protects the Lower Respiratory Tract of Mice from Lethal Influenza Virus Infection.

Authors:  Karen Ivinson; Georgia Deliyannis; Leanne McNabb; Lara Grollo; Brad Gilbertson; David Jackson; Lorena E Brown
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

8.  Biological characteristics of a cold-adapted influenza A virus mutation residing on a polymerase gene.

Authors:  T Odagiri; A Tosaka; N Ishida; H F Maassab
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.

Authors:  E Bart Tarbet; Stephanie Hamilton; Almut H Vollmer; Angela Luttick; Wy Ching Ng; Melinda Pryor; Brett L Hurst; Simon Crawford; Donald F Smee; Simon P Tucker
Journal:  J Antimicrob Chemother       Date:  2014-04-28       Impact factor: 5.790

Review 10.  Heterosubtypic immunity to influenza A virus: where do we stand?

Authors:  Kristie M Grebe; Jonathan W Yewdell; Jack R Bennink
Journal:  Microbes Infect       Date:  2008-07-09       Impact factor: 2.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.